Israel Englander Glaukos Corp Call Options Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$113.62 - $135.39 $590,824 - $704,027	-5,200 Reduced 50.98%	5,000 $651,000
Q2 2024 Aug 14, 2024	BUY	$89.48 - $118.35 $912,696 - $1.21 Million	10,200 New	10,200 $1.21 Million
Q4 2023 Feb 14, 2024	BUY	$59.53 - $85.11 $1.76 Million - $2.52 Million	29,600 Added 65.78%	74,600 $5.93 Million
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $2.04 Million - $3.2 Million	45,000 New	45,000 $3.2 Million

341

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.